Literature DB >> 9769

Preliminary report: parenteral Lorazepam in induced epileptic states in man.

A Waltregny, J Dargent.   

Abstract

The anticonvulsive effect of Lorazepam -- one of the newer diazepines -- has been tested in 10 patients with induced epileptic conditions under continuous polygraphic control. The quantitative analysis of the paroxysmal discharges -- i.e. the evolution of the "paroxysmal index" -- shows that 5 mg IV Lorazepam normalize the tracings in 2.3 minutes. Parenteral Lorazepam inhibits pharmacologically-induced electroencephalographic abnormalities in man. Its action is slightly delayed. No effect on cardiac or respiratory function, or muscle tone was noted.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 9769

Source DB:  PubMed          Journal:  Acta Neurol Belg        ISSN: 0300-9009            Impact factor:   2.396


  3 in total

1.  Neurology-important advances in clinical medicine: Lorazepam: a new antiepileptic drug in status epilepticus therapy.

Authors:  N S Chu
Journal:  West J Med       Date:  1982-10

Review 2.  Perioperative substitution of anti-epileptic drugs.

Authors:  Wilma S W Wichards; Alfred F A M Schobben; Frans S S Leijten
Journal:  J Neurol       Date:  2013-09-01       Impact factor: 4.849

Review 3.  Lorazepam: a review of its clinical pharmacological properties and therapeutic uses.

Authors:  B Ameer; D J Greenblatt
Journal:  Drugs       Date:  1981-03       Impact factor: 9.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.